vs

Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $5.0M, roughly 1.5× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -7.5%, a 1.9% gap on every dollar of revenue. On growth, cbdMD, Inc. posted the faster year-over-year revenue change (-1.9% vs -4.5%). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -1.5%).

Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

MGLD vs YCBD — Head-to-Head

Bigger by revenue
MGLD
MGLD
1.5× larger
MGLD
$7.6M
$5.0M
YCBD
Growing faster (revenue YoY)
YCBD
YCBD
+2.6% gap
YCBD
-1.9%
-4.5%
MGLD
Higher net margin
YCBD
YCBD
1.9% more per $
YCBD
-5.6%
-7.5%
MGLD
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
-1.5%
MGLD

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
MGLD
MGLD
YCBD
YCBD
Revenue
$7.6M
$5.0M
Net Profit
$-576.0K
$-283.1K
Gross Margin
74.0%
59.8%
Operating Margin
-8.3%
-5.7%
Net Margin
-7.5%
-5.6%
Revenue YoY
-4.5%
-1.9%
Net Profit YoY
67.0%
-1975.7%
EPS (diluted)
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGLD
MGLD
YCBD
YCBD
Q4 25
$7.6M
$5.0M
Q3 25
$7.0M
$4.7M
Q2 25
$7.2M
$4.6M
Q1 25
$7.0M
$4.7M
Q4 24
$8.0M
$5.1M
Q3 24
$7.9M
$4.6M
Q2 24
$8.3M
$5.2M
Q1 24
$7.9M
$4.4M
Net Profit
MGLD
MGLD
YCBD
YCBD
Q4 25
$-576.0K
$-283.1K
Q3 25
$-356.0K
$-680.0K
Q2 25
$-1.5M
$-895.3K
Q1 25
$-1.0M
$-480.8K
Q4 24
$-1.7M
$15.1K
Q3 24
$-1.6M
$-152.8K
Q2 24
$-1.9M
$459.7K
Q1 24
$-529.0K
$-3.0M
Gross Margin
MGLD
MGLD
YCBD
YCBD
Q4 25
74.0%
59.8%
Q3 25
77.0%
58.8%
Q2 25
67.8%
61.5%
Q1 25
75.0%
62.3%
Q4 24
74.1%
66.5%
Q3 24
73.1%
53.9%
Q2 24
72.5%
65.8%
Q1 24
70.5%
59.0%
Operating Margin
MGLD
MGLD
YCBD
YCBD
Q4 25
-8.3%
-5.7%
Q3 25
-18.2%
-14.5%
Q2 25
-16.5%
-19.6%
Q1 25
-21.4%
-10.2%
Q4 24
-22.8%
-1.7%
Q3 24
-27.4%
-6.9%
Q2 24
-33.3%
-7.4%
Q1 24
-18.7%
-35.4%
Net Margin
MGLD
MGLD
YCBD
YCBD
Q4 25
-7.5%
-5.6%
Q3 25
-5.1%
-14.4%
Q2 25
-20.4%
-19.4%
Q1 25
-14.4%
-10.1%
Q4 24
-21.8%
0.3%
Q3 24
-20.1%
-3.4%
Q2 24
-22.5%
8.9%
Q1 24
-6.7%
-68.8%
EPS (diluted)
MGLD
MGLD
YCBD
YCBD
Q4 25
$-0.01
Q3 25
$-0.01
Q2 25
$-0.04
Q1 25
$-0.02
Q4 24
$-0.04
Q3 24
$-0.04
Q2 24
$-0.05
$-0.15
Q1 24
$-0.01
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGLD
MGLD
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$11.6M
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$22.7M
$9.0M
Total Assets
$27.8M
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGLD
MGLD
YCBD
YCBD
Q4 25
$11.6M
$3.4M
Q3 25
$12.5M
$2.3M
Q2 25
$12.8M
$1.1M
Q1 25
$15.6M
$1.8M
Q4 24
$14.9M
$2.0M
Q3 24
$17.5M
$2.5M
Q2 24
$15.0M
$2.4M
Q1 24
$16.1M
$2.1M
Stockholders' Equity
MGLD
MGLD
YCBD
YCBD
Q4 25
$22.7M
$9.0M
Q3 25
$22.9M
$7.2M
Q2 25
$23.0M
$6.1M
Q1 25
$24.3M
$665.8K
Q4 24
$23.4M
$1.8M
Q3 24
$25.5M
$2.0M
Q2 24
$26.6M
$3.0M
Q1 24
$28.4M
$3.1M
Total Assets
MGLD
MGLD
YCBD
YCBD
Q4 25
$27.8M
$11.8M
Q3 25
$28.4M
$10.4M
Q2 25
$30.4M
$9.9M
Q1 25
$33.5M
$10.9M
Q4 24
$33.0M
$11.5M
Q3 24
$35.9M
$10.6M
Q2 24
$32.9M
$13.8M
Q1 24
$33.7M
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGLD
MGLD
YCBD
YCBD
Operating Cash FlowLast quarter
$-908.0K
$-812.5K
Free Cash FlowOCF − Capex
$-977.3K
FCF MarginFCF / Revenue
-19.5%
Capex IntensityCapex / Revenue
0.0%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGLD
MGLD
YCBD
YCBD
Q4 25
$-908.0K
$-812.5K
Q3 25
$-533.0K
$-240.7K
Q2 25
$-3.3M
$-704.2K
Q1 25
$-1.2M
$-189.5K
Q4 24
$-770.0K
$-317.9K
Q3 24
$-893.0K
$167.4K
Q2 24
$-1.9M
$289.8K
Q1 24
$-658.0K
$-704.1K
Free Cash Flow
MGLD
MGLD
YCBD
YCBD
Q4 25
$-977.3K
Q3 25
$-562.0K
$-243.6K
Q2 25
$-3.4M
$-705.7K
Q1 25
$-205.0K
Q4 24
$-776.0K
$-482.3K
Q3 24
$-940.0K
$157.4K
Q2 24
$-2.0M
Q1 24
$-708.7K
FCF Margin
MGLD
MGLD
YCBD
YCBD
Q4 25
-19.5%
Q3 25
-8.1%
-5.2%
Q2 25
-46.8%
-15.3%
Q1 25
-4.3%
Q4 24
-9.7%
-9.4%
Q3 24
-11.9%
3.5%
Q2 24
-23.8%
Q1 24
-16.2%
Capex Intensity
MGLD
MGLD
YCBD
YCBD
Q4 25
0.0%
3.3%
Q3 25
0.4%
0.1%
Q2 25
0.7%
0.0%
Q1 25
0.0%
0.3%
Q4 24
0.1%
3.2%
Q3 24
0.6%
0.2%
Q2 24
0.7%
0.0%
Q1 24
0.0%
0.1%
Cash Conversion
MGLD
MGLD
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MGLD
MGLD

Fund Management Related Party$4.6M60%
Food Products$1.7M22%
Beauty Products$1.2M15%
Other$268.0K4%

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons